AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2018

Feb 5, 2018

30071_dirs_2018-02-05_73995835-ece5-46d0-bb11-cb5af31a1eba.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-02-01

Reporting Person: McHale Richard (President, RC Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-01	ResMed Common Stock	S	2000	$100.12	Disposed	12204	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $100.05 to $100.14. The price reported above reflects the weighted average sale price.